Evidence map›Paper›PMID 42421858›Full record

ArticleEFSA journal. European Food Safety Authority2026

Use of conversion factors for the setting of MRLs of prothioconazole.

European Food Safety Authority (EFSA), Giulia Bellisai, Giovanni Bernasconi, Luis Carrasco Cabrera, Irene Castellan, Monica Del Aguila, Lucien Ferreira, Luna Greco, Renata Leuschner, Andrea Mioč and 9 more

Abstract read
In one paragraph

Article in EFSA journal. European Food Safety Authority, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Use of conversion factors for the setting of MRLs of prothioconazole.EFSA journal. European Food Safety Authority · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

European Food Safety Authority (EFSA)
Giulia Bellisai
Giovanni Bernasconi
Luis Carrasco Cabrera
Irene Castellan
Monica Del Aguila
Lucien Ferreira
Luna Greco
Renata Leuschner
Andrea Mioč
Stefanie Nave
Hermine Reich
Silvia Ruocco
Alessia Pia Scarlato
Marta Szot
Anne Theobald
Manuela Tiramani
Alessia Verani
Elena Zioga

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Bayer AG Crop Science Division submitted a request to the competent national authority in France to use conversion factors for the setting of maximum residue levels (MRLs) for prothioconazole. The applicant did not propose modification of the existing EU MRLs for prothioconazole, as currently set in Regulation (EU) 2024/1318. The data provided in the previous EFSA outputs and submitted under the present assessment were sufficient to derive crop-specific conversion factors for all crops under consideration, except for pulses, head cabbage and flowering brassica. For onions and shallots, the submitted data are considered to support a less conservative good agricultural practice (GAP). Moreover, the data submitted were found sufficient to confirm tentative MRLs for prothioconazole in leek, Brussels sprouts, barley, oat, wheat, rye grain and in commodities of animal origin. An updated EU livestock dietary burden indicates that lower EU MRLs would be sufficient in liver, kidney and edible offal of ruminants, swine and poultry and in the fat of ruminants and swine. EFSA concluded that the existing EU uses of prothioconazole will not result in a consumer exposure exceeding the toxicological reference values and therefore are unlikely to pose a risk to consumers' health. All conclusions derived under the present assessment are considered provisional and might need to be reconsidered once the decision on the renewal of approval of prothioconazole (and related new endpoints) is implemented by the European Commission.

Indexed as

consumer risk assessmentconversion factorsMRLpesticideprothiconazole

Identifiers

PMID42421858
PMCPMC13343310

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.